Navigation Links
Two screen test and treat screening for cervical cancer

ned using human Papilloma virus (HPV) DNA testing and visual inspection with VIA.

The researchers found that using Two screen and treat procedures the incidence of cervical cancers and cervical lesions was diagnosed early and it offers a great option of treating the cancer lesions by using Cryotherapy effectively even in economically weaker section using reduced hospital equipments.

Experts View:
Professor Lynette Denny and his team said, This trial has shown that screening and treating women based on the results of two alternative screening tests to cytology, HPV DNA testing and VIA, is safe and has a significant impact on the prevalence of CIN 2+ among women participating in such a program. In low-resource settings, screen-and-treat approaches may be able to reduce the risk of a common and easily preventable cancer in women.

Paul D. Blumenthal, M.D., M.P.H., of Johns Hopkins University, Baltimore said, When faced with a challenge, identifying and seizing an opportunity can be the first step toward triumph. That is what public health approaches are often about. An important lesson from the work of Brewster et al and Denny et al is that whether in southern California or southern Africa, safe, acceptable, effective, and pragmatic public health approaches to cervical cancer prevention can be designed
'"/>




Page: 1 2

Related medicine news :

1. A sunscreen from the sea
2. Need for Colon cancer screening
3. DNA biochip for genetic screening
4. Breast screening among diabetic women
5. Fast screening for macular degeneration
6. Inadequate proof to justify routine prostate screen
7. New virtual colonoscopy procedure for easier colon screening
8. Hearing loss can be detected by simple screening
9. MRI screenings may be better to identify breast cancer
10. Oral cancer screenings to reduce the mortality rates
11. Appendectomy need reduced with CT screening
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Oncologist at the Children's Hospital of Philadelphia to Chair International Childhood Cancer Organization 2Health News:Oncologist at the Children's Hospital of Philadelphia to Chair International Childhood Cancer Organization 3Health News:Oncologist at the Children's Hospital of Philadelphia to Chair International Childhood Cancer Organization 4Health News:Workforce Alliance Earns Grant to Train Health Care Workers 2Health News:Workforce Alliance Earns Grant to Train Health Care Workers 3Health News:Independence Blue Cross Supports Pennsylvania Fitness Program with Grants to 10 Area Schools 2Health News:Independence Blue Cross Supports Pennsylvania Fitness Program with Grants to 10 Area Schools 3Health News:Reliv International Hires Director of Strategic Development 2Health News:U.S. Bishops Urge Senators to Support Nelson-Hatch-Casey Amendment on Health Care Reform; Urge Constituents to Back it 2Health News:U.S. Bishops Urge Senators to Support Nelson-Hatch-Casey Amendment on Health Care Reform; Urge Constituents to Back it 3Health News:U.S. Bishops Urge Senators to Support Nelson-Hatch-Casey Amendment on Health Care Reform; Urge Constituents to Back it 4Health News:U.S. Bishops Urge Senators to Support Nelson-Hatch-Casey Amendment on Health Care Reform; Urge Constituents to Back it 5
Breaking Medicine Technology:ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 2ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 3ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 5ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 6ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 7Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 2Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 3Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 4Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 5Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual Meeting 6FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 2FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 3aTyr Pharma to Present at Japan Biopharma Partnering Conference 58295 1aTyr Pharma to Present at Japan Biopharma Partnering Conference 58295 2Free Wheelchair Mission Listed by Ministry Watch as Top 30 Shining Light Exemplary Ministry for 2008 58293 1Free Wheelchair Mission Listed by Ministry Watch as Top 30 Shining Light Exemplary Ministry for 2008 58293 2Virginia Now Owns Three Top National Business Rankings 14267 1Virginia Now Owns Three Top National Business Rankings 14267 2